Relevant bibliographies by topics / Heart – Surgery – Risk factors / Books
To see the other types of publications on this topic, follow the link: Heart – Surgery – Risk factors.

Books on the topic 'Heart – Surgery – Risk factors'

Author: Grafiati
Published: 4 June 2021
Last updated: 30 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Heart – Surgery – Risk factors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Andris, Kazmers, ed. Cardiac risk assessment before vascular surgery. Armonk, NY: Futura Pub. Co., 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Satō, Atsuko. Coronary artery disease, cardiac arrest, and bypass surgery: Risk factors, health effects, and outcomes. Hauppauge, N.Y: Nova Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meeting, International Society for Heart Transplantation. Blood saving in open heart surgery: 9th Annual Meeting of the International Society for Heart Transplantation, Munich, FR Germany, April 22-23, 1989. Stuttgart ; New York: Schattauer, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

1940-, Roberts Robert, ed. Coronary heart disease and risk factors. Mount Kisco, NY: Futura Pub. Co., 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1961-, Gaziano J. Michael, ed. Atlas of cardiovascular risk factors. Philadelphia: Developed by Current Medicine, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1959-, Osborn Kevin, and Philip Lief Group, eds. Heart disease: Reducing your risk. New York: Bantam Books, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Reinecke, Holger. Extra-cardiac risk factors for. Aachen: Shaker, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Uri, Goldbourt, De Faire Ulf, and Berg Kåre, eds. Genetic factors in coronary heart disease. Dordrecht: Kluwer Academic, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schabas, Richard. Heart health: A report of the Ontario heart health survey. Toronto, Ont: Ministry of Health, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Smith, Phillipa Jane. Prevention of coronary heart disease: Communicating the risk factors. [Guildford]: [University of Surrey], 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Stehle, G. Coronary risk factors in Japan and China. Berlin: Springer-Verlag, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Health, Ontario Ministry of. Ontario heart health survey: Executive summary. Toronto, Ont: Ministry of Health, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Canada, Canada Health. The Healthy heart kit. Ottawa, Ont: Health Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

H, Anderson Mark. Risk assessment of ventricular tachyarrhythmias. Armonk, N.Y: Futura Pub. Co., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

1944-, Shepherd J., ed. Coronary risk factors revisited: Proceedings of the International Symposium on Coronary Risk Factors Revisited, Gleneagles, Scotland, 11-14 December 1988. Amsterdam: Excerpta Medica, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

McPherson, Klim. Coronary heart disease: Estimating the impact of changes in risk factors. London: TSO, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Young, T. Kue. Cardiovascular diseases and risk factors among North American Indians. Winnipeg: Northern Health Research Unit, Dept. of Community Health Sciences, Faculty of Medicine, University of Manitoba, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Jungblut, Hans-Dieter. Erfassung und Bewertung des Krebsrisikos beim Menschen. Mainz: Akademie der Wissenschaften und der Literatur, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Coronary heart disease & risk factor management: A nursing perspective. Philadelphia: W.B. Saunders, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Moser, Marvin. Week by week to a strong heart: An action plan for preventing or treating heart disease and other circulatory problems. Emmaus, PA: Rodale Press, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Frohlich, Edward D. Take heart: Cut your inherited risks of heart disease. New York: Crown Publishers, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Preventive cardiology. Baltimore: Williams & Wilkins, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Marchie, Augustine. Effect of almonds in diets to reduce coronary heart disease risk factors. Ottawa: National Library of Canada, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Lopes, Philippe. The relationships between respiratory sinus arrhythmia and coronary heart disease risk factors. [s.l: The Author], 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Coronary heart disease: Risks and reasons. London: Current Medical Literature, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

DeVane, Matthew S. Heart Smart. New York: John Wiley & Sons, Ltd., 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Kris-Etherton, P. M. Trans fatty acids and coronary heart disease risk. Washington, D.C: ILSI Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

C, Vlay Stephen, ed. Medical care of the cardiac surgical patient. Boston: Blackwell Scientific Publications, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Complications In The Cath Lab Risk Factors Management And Bailout Techniques. Lippincott Williams & Wilkins, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

T, Mangano Dennis, ed. Preoperative cardiac assessment. Philadelphia: Lippincott, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Blood Saving in Open Heart Surgery. John Wiley & Sons, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

The effects of supervised cardiac rehabilitation on selected coronary artery disease risk factors following coronary artery bypass graft surgery. 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

The effects of supervised cardiac rehabilitation on selected coronary artery disease risk factors following coronary artery bypass graft surgery. 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

A, Shawl Fayaz, ed. Supported complex and high risk coronary angioplasty. Boston: Kluwer Academic Publishers, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Nashef, Samer, and Terence English. Naked Surgeon: The Power and Peril of Transparency in Medicine. Scribe Publications, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Nashef, Samer. Naked Surgeon: The Power and Peril of Transparency in Medicine. Scribe Publications, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Balik, Martin. Perioperative cardiac care of the high-risk non-cardiac patient. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0076.

Full text
Abstract:
Non-cardiac surgery conveys a cardiac risk related to the status of the patient’s cardiovascular system. Cardiac-related risk of surgery can be assessed by integrating the risk and urgency of the procedure with cardiovascular risk factors, which include age, ischaemic heart disease, heart failure, stroke, diabetes mellitus, chronic obstructive pulmonary disease, and renal dysfunction. An individual assessment can include simple multivariate scoring systems, developed with the aim of evaluating cardiac risk prior to non-cardiac surgery. Patient assessment can be extended for indicated additional tests. The indications for further cardiac testing and treatments are the same as in the non-operative setting, but their timing is dependent on the urgency of surgery, and patient-specific and surgical risk factors. A delay in surgery, due to the use of both non-invasive and invasive preoperative testing, should be limited to those circumstances in which the results of such tests will clearly affect patient management. In high-risk patients, the result of the cardiac assessment helps to choose adequate perioperative monitoring and to indicate for an intensive care unit stay perioperatively. Chronic medications can be adjusted, according to the current knowledge on perioperative management. Drugs with the potential to reduce the incidence of post-operative cardiac events and mortality include beta-blockers, statins, and aspirin. Chronic platelet anti-aggregation and anticoagulation therapies have to be adapted by weighing the risk of bleeding against the risk of thrombotic complications.
APA, Harvard, Vancouver, ISO, and other styles
38

Balik, Martin. Perioperative cardiac care of the high-risk non-cardiac patient. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199687039.003.0076_update_001.

Full text
Abstract:
Non-cardiac surgery conveys a cardiac risk related to the status of the patient’s cardiovascular system. Cardiac-related risk of surgery can be assessed by integrating the risk and urgency of the procedure with cardiovascular risk factors, which include age, ischaemic heart disease, heart failure, stroke, diabetes mellitus, chronic obstructive pulmonary disease, and renal dysfunction. An individual assessment can include simple multivariate scoring systems, developed with the aim of evaluating cardiac risk prior to non-cardiac surgery. Patient assessment can be extended for indicated additional tests. The indications for further cardiac testing and treatments are the same as in the non-operative setting, but their timing is dependent on the urgency of surgery, and patient-specific and surgical risk factors. A delay in surgery, due to the use of both non-invasive and invasive preoperative testing, should be limited to those circumstances in which the results of such tests will clearly affect patient management. In high-risk patients, the result of the cardiac assessment helps to choose adequate perioperative monitoring and to indicate for an intensive care unit stay perioperatively. Chronic medications can be adjusted, according to the current knowledge on perioperative management. Drugs with the potential to reduce the incidence of post-operative cardiac events and mortality include beta-blockers, statins, and aspirin. Chronic platelet anti-aggregation and anticoagulation therapies have to be adapted by weighing the risk of bleeding against the risk of thrombotic complications.
APA, Harvard, Vancouver, ISO, and other styles
39

Balik, Martin. Perioperative cardiac care of the high-risk non-cardiac patient. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199687039.003.0076_update_002.

Full text
Abstract:
Non-cardiac surgery conveys a cardiac risk related to the status of the patient’s cardiovascular system. Cardiac-related risk of surgery can be assessed by integrating the risk and urgency of the procedure with cardiovascular risk factors, which include age, ischaemic heart disease, heart failure, stroke, diabetes mellitus, chronic obstructive pulmonary disease, and renal dysfunction. An individual assessment can include simple multivariate scoring systems, developed with the aim of evaluating cardiac risk prior to non-cardiac surgery. Patient assessment can be extended for indicated additional tests. The indications for further cardiac testing and treatments are the same as in the non-operative setting, but their timing is dependent on the urgency of surgery, and patient-specific and surgical risk factors. A delay in surgery, due to the use of both non-invasive and invasive preoperative testing, should be limited to those circumstances in which the results of such tests will clearly affect patient management. In high-risk patients, the result of the cardiac assessment helps to choose adequate perioperative monitoring and to indicate for an intensive care unit stay perioperatively. Chronic medications can be adjusted, according to the current knowledge on perioperative management. Drugs with the potential to reduce the incidence of post-operative cardiac events and mortality include beta-blockers, statins, and aspirin. Chronic platelet anti-aggregation and anticoagulation therapies have to be adapted by weighing the risk of bleeding against the risk of thrombotic complications.
APA, Harvard, Vancouver, ISO, and other styles
40

Atlas Of Atherosclerosis And Metabolic Syndrome. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Grundy, Scott M. Atlas of Atherosclerosis and Metabolic Syndrome. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Grundy, Scott M. Atlas of Atherosclerosis and Metabolic Syndrome. Springer New York, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Barnard, Matthew, and Nicola Jones. Intensive care management after cardiothoracic surgery. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0368.

Full text
Abstract:
Management of the post-cardiothoracic surgical patient follows general principles of intensive care, but incorporates certain unique considerations. In cardiac surgical patients peri-operative ischaemia, arrhythmias and ventricular dysfunction mandate specific monitoring requirements, and individual pharmacological and mechanical support. Suspicion of myocardial ischaemia should not only lead to pharmacological treatment, but also consideration of urgent angiography to exclude coronary graft occlusion. Ventricular dysfunction may be pre-existing or attributable to intra-operative myocardial ‘stunning’. Catecholamines and phosphodiesterase inhibitors are the mainstay of therapy. Rarely, intra-aortic balloon pumping or ventricular assist devices are required. Significant bleeding (with potential cardiac tamponade), respiratory compromise, acute kidney injury, neurological injury, and deep sternal wound infection each occur in ~2–3% of cardiac surgical patients. Each of these has individual risk factors and specific management considerations. General guidelines for patients who have undergone thoracic surgery include early extubation, fluid restriction, effective analgesia, and protective lung ventilation. Thoracic patients are at risk of atelectasis, respiratory infection, bronchial air leak, and right ventricular failure. Positive pressure ventilation is avoided whenever possible particularly after pneumonectomy, but is sometimes necessary in compromised patients. Air leaks are common. Alveolopleural fistulae usually improve with conservative management,whereas bronchopleural fistulae are more likely to require surgical intervention. Lung surgery is high risk for patients with ischaemic heart disease. Patients with pre-existing elevated pulmonary vascular resistance may exhibit right ventricular dysfunction and may fail to cope with a further increase in pulmonary vascular resistance consequent to lung resection. Lung collapse and infection are constant risks throughout the entire post-operative period.
APA, Harvard, Vancouver, ISO, and other styles
44

Hert, Stefan De, and Patrick Wouters. Heart disease and anaesthesia. Edited by Philip M. Hopkins. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0083.

Full text
Abstract:
Cardiovascular disease is a leading cause of mortality. Hypertension is one of the major risk factors for cardiovascular disease. Classically, hypertension is subdivided according to the aetiology into primary and secondary hypertension. Ischaemic heart disease constitutes a major concern for perioperative morbidity and mortality. Therefore important efforts are directed towards the identification of the patient at risk for perioperative cardiac complications and towards optimization of the cardiac status before intervention. Cardiac rhythm disturbances fall into two general classes: bradyarrhythmias and tachyarrhythmias. While single isolated extra or skipped heart beats are usually harmless, serious heart rhythm disturbances are caused by an underlying heart disease. Valvular heart disease refers to any disease process involving any valve of the heart. Valvular heart disease may be as a result of a stenosis or an insufficiency of the valve, or both. It is characterized by pressure or volume overload to the atria and the ventricles (or both). It is this overload that will be responsible for the symptomatology of the disease. As a result of significant advances in prenatal diagnosis, cardiac surgery, interventional cardiology, and perioperative medicine, about 90% of infants with congenital heart disease are currently expected to reach adulthood. Management of these patients requires insight into (1) the primary cardiac lesion, (2) the type of cardiac surgical or interventional procedure(s) performed, (3) the presence of residual defects or sequelae, (4) the current physical status (i.e. balanced vs unbalanced), (5) the effects of surgery or pregnancy on their pathophysiological condition, and (6) the presence of comorbidity.
APA, Harvard, Vancouver, ISO, and other styles
45

Mittal. Heart Disease and Risk Factors. Ajanta Publications (India), Ajanta Books International, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Coronary Risk Factors Update. W.B. Saunders Company, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Barrett, Chad L. Abdominal Injuries: Risk Factors, Management and Prognosis. Nova Science Publishers, Incorporated, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Akira, Yamamoto, ed. Multiple risk factors in cardiovascular disease. Edinburgh: Churchill Livingstone, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Exercise and coronary heart disease risk factors. 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Exercise and coronary heart disease risk factors. 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Heart – Surgery – Risk factors' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography